Citi analyst Andrew Baum raised his price target for Bristol-Myers Squibb (BMY) to $78 from $72 saying three developments over the last week have increased...
Guggenheim analyst Matthew DiFrisco upgraded Wendy's to Buy from Neutral with an $18 price target. The shares closed yesterday down 5c to $15.70. The recent...
Shares of Sorrento Therapeutics (SRNE) are rallying after Matthew Herper of Forbes reported that Celularity, a company spun out of Celgene (CELG), raised $250M with...
Coca-Cola Company said its board approved the company's 56th consecutive annual dividend increase, raising the quarterly dividend 5.4%, to 39c from 37c per common share....
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Bristol-Myers (BMY) upgraded to Overweight from Equal Weight at...
William Blair analyst Louie DiPalma says that with Gogo (GOGO) shares near an all-time low and down 20% year-to-date, sentiment is "overly negative." The stock...
As previously reported, Morgan Stanley analyst David Risinger upgraded Bristol-Myers (BMY) to Overweight from Equal Weight as he has become more optimistic on the immuno-oncology...
Bill Ackman's Pershing Square Capital Management disclosed in an SEC filing its holdings as of December 31, 2017. Pershing Square's one new buy during the...
David Tepper's Appaloosa Management disclosed in an SEC filing its holdings as of December 31, 2017. Appaloosa's 11 new buys during the fourth quarter included,...